Alliance Clinical Network Merges With Atlas Clinical Research

Julius Clinical (Ampersand-backed) Merges with Peachtree BioResearch Solutions

May 14, 2025

Healthcare Services

Julius Clinical, a Netherlands-based CRO supported by Ampersand Capital Partners, has merged with Peachtree BioResearch Solutions, a specialized CNS CRO based in Georgia, USA. The merger creates a larger, fully integrated global CRO with expanded CNS capabilities and enhanced access across Europe and North America.

Alliance for Multispecialty Research (AMR) Acquires Affinity Health

December 15, 2023

Healthcare Services

Alliance for Multispecialty Research (AMR) has acquired Affinity Health, a clinical research services provider founded in 2015. The deal adds Affinity's sites and eight principal investigators to AMR's network, expanding AMR's geographic footprint (including Chicago and Nashville) and strengthening its clinical trial capabilities and patient diversity.

Alcanza Clinical Research Acquires Accel Research Sites Network

July 18, 2023

Healthcare Services

Alcanza Clinical Research has acquired Accel Research Sites Network, a Florida-headquartered multi-specialty clinical research site network with 22 locations across the Southeast U.S. Accel's operations will be integrated into Alcanza's centralized platform while retaining its brand, expanding Alcanza's geographic footprint, therapeutic capabilities, and access to diverse patient populations.

Atlas Clinical Research Acquires Suburban Research Associates

July 12, 2023

Healthcare Services

Atlas Clinical Research, a therapeutically-driven clinical site network and portfolio company of healthcare investor BPOC, has added Suburban Research Associates — a two-location psychiatric clinical research site in Media and West Chester, Pennsylvania — to its platform. The partnership will expand Atlas's site network and give Suburban access to centralized technology, operational support and broader sponsor/CRO connectivity to accelerate psychiatric clinical trials and patient reach.

Amulet Capital Partners Acquires Alliance Clinical Network

May 22, 2023

Healthcare Services

Amulet Capital Partners has acquired Alliance Clinical Network (ACN), a Dallas-based clinical site platform that owns and operates six research sites across California, Nevada and Texas. ACN will continue to be led by founder and CEO Anthony Abey (who retains a significant ownership stake) and will partner with Amulet to expand its footprint, therapeutic capabilities and strategic acquisitions to serve pharmaceutical sponsors and CROs.

Altasciences Acquires Alliance Contract Pharma

February 27, 2020

Pharmaceuticals

Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.